SYK has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SYK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Stryker's earnings per share without non-recurring items for the three months ended in Jun. 2023 was $1.93. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2023 was $7.08.
During the past 12 months, Stryker's average earnings per share (NRI) Growth Rate was 30.40% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 4.00% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 6.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Stryker's EPS without NRI or its related term are showing as below:
During the past 13 years, Stryker's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 153.00% per year. The lowest was -42.60% per year. And the median was 19.60% per year.
Stryker's EPS (Diluted) for the three months ended in Jun. 2023 was $1.93. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $7.08.
Stryker's EPS (Basic) for the three months ended in Jun. 2023 was $1.95. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2023 was $7.15.
The historical data trend for Stryker's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Stryker's EPS without NRI, along with its competitors' market caps and EPS without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Stryker's EPS without NRI distribution charts can be found below:
* The bar in red indicates where Stryker's EPS without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and Non Operating Income need to subtracted from the total net income first.
EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stryker (NYSE:SYK) EPS without NRI Explanation
A Non Operating Income refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Thank you for viewing the detailed overview of Stryker's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.
James Andrew Pierce | officer: Group President | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Spencer S Stiles | officer: Group President | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Giovanni Caforio | director | BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543 |
Skeete Tatum Lisa M | director | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Robert S Fletcher | officer: VP, Chief Legal Officer | 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002 |
Viju Menon | officer: Group President | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Sherilyn S Mccoy | director | JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Rajeev Suri | director | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Mary K Brainerd | director | 8170 33RD AVENUE SOUTH, BLOOMINGTON MN 55425 |
Graham A Mclean | officer: President, Asia-Pacific | 1 CORPORATE AVENUE ROWVILLE, VICTORIA C3 3178 |
Glenn S Boehnlein | officer: Vice President, CFO | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
M Kathryn Fink | officer: VP, Global Human Resources | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Yin C Becker | officer: VP, Comm. & Public Affairs | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Bijoy Sagar | officer: VP, Chief Information Officer | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
Michael Damon Hutchinson | officer: General Counsel | 2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
From GuruFocus
By Business Wire 02-17-2023
By Business Wire 03-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.